Bioequivalence studies for GCC submission [Design Issues]

posted by drgunasakaran1  – 2025-01-31 04:20 (15 d 07:31 ago) – Posting: # 24354
Views: 270

❝ Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

If the CRO has been approved in the last two years by two of the following drug regulatory agencies such as US FDA, Health Canada, TGA - Australia, UK MHRA, EMA, or WHO, along with one additional authority from the list, then you can include CRO name in the list of bioequivalence centers approved by GCC and you can conduct studies for GCC submission.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
88 visitors (0 registered, 88 guests [including 8 identified bots]).
Forum time: 11:52 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5